These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16788360)

  • 1. Increased introduction, advertising, and sales of preventive drugs during 1986-2002 in Sweden.
    Nilsson JL; Melander A
    J Ambul Care Manage; 2006; 29(3):238-49. PubMed ID: 16788360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing face of pharmaceutical advertising. A look at medical journals reveals a new era in advertising.
    Weeks WB; Wallace AE; Kimberly BC
    Mark Health Serv; 2001; 21(3):27-30. PubMed ID: 11525138
    [No Abstract]   [Full Text] [Related]  

  • 3. Features of sales promotion in cigarette magazine advertisements, 1980-1993: an analysis of youth exposure in the United States.
    Pucci LG; Siegel M
    Tob Control; 1999; 8(1):29-36. PubMed ID: 10465813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of the advertising of nine new drugs in the general practice literature.
    Jones M; Greenfield S; Bradley C
    J Clin Pharm Ther; 1999 Dec; 24(6):451-60. PubMed ID: 10651978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Strong lobbying for direct -to-consumer advertising of prescription drugs. Beneficial for the patient or for the increase of sales?].
    Hjemdahl P
    Lakartidningen; 2002 May; 99(21):2374-5. PubMed ID: 12090161
    [No Abstract]   [Full Text] [Related]  

  • 6. The construction of gender and mental health in Nordic psychotropic-drug advertising.
    Lövdahl U; Riska E
    Int J Health Serv; 2000; 30(2):387-406. PubMed ID: 10862382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advertising for psychotropic drugs in the Nordic countries: metaphors, gender and life situations.
    Riska E; Hägglund U
    Soc Sci Med; 1991; 32(4):465-71. PubMed ID: 2024162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of prescription drugs to consumers.
    Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
    N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical advertisements in medical journals received in a medical clinic: are we having "too much of a good thing"?
    Lohiya S
    J Natl Med Assoc; 2005 May; 97(5):718-20. PubMed ID: 15926650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of promotion on pharmaceutical demand.
    Mackowiak JI; Gagnon JP
    Soc Sci Med; 1985; 20(11):1191-7. PubMed ID: 4023756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6.
    Aronson JK; Green AR
    Br J Clin Pharmacol; 2019 Sep; 85(9):1901-1906. PubMed ID: 31158301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The new antidepressive agents. Is it rational to prescribe drugs or a "mental brace"?].
    Håkansson J
    Lakartidningen; 1996 Nov; 93(45):4000-2. PubMed ID: 8984251
    [No Abstract]   [Full Text] [Related]  

  • 13. Press coverage and sales of Xenical in Sweden, 1998-2000.
    Brounéus F; Dahlin A; Beermann B
    Eur J Clin Pharmacol; 2005 Jun; 61(4):285-9. PubMed ID: 15895270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications, 1975-2000.
    Nelson CP; Bloom DA
    J Urol; 2001 Dec; 166(6):2317-20. PubMed ID: 11696770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advertising of antihypertensive medicines and prescription sales in Australia.
    Vitry A; Lai YH
    Intern Med J; 2009 Nov; 39(11):728-32. PubMed ID: 19226422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.
    Carlsten A; Wennberg M; Bergendal L
    J Clin Pharm Ther; 1996 Dec; 21(6):423-30. PubMed ID: 9201570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of advertisements in the Journal of the American Academy of Dermatology, 1980 and 1990.
    Hogan DJ; Sarel D; Canas A; Bellman B; Eaglstein W; Hogan LA; Kramer J
    J Am Acad Dermatol; 1993 Jun; 28(6):993-7. PubMed ID: 8496463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.